1. Home
  2. BDSX vs BDL Comparison

BDSX vs BDL Comparison

Compare BDSX & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • BDL
  • Stock Information
  • Founded
  • BDSX 2005
  • BDL 1959
  • Country
  • BDSX United States
  • BDL United States
  • Employees
  • BDSX N/A
  • BDL N/A
  • Industry
  • BDSX Precision Instruments
  • BDL Restaurants
  • Sector
  • BDSX Health Care
  • BDL Consumer Discretionary
  • Exchange
  • BDSX Nasdaq
  • BDL Nasdaq
  • Market Cap
  • BDSX 53.2M
  • BDL 57.7M
  • IPO Year
  • BDSX 2020
  • BDL N/A
  • Fundamental
  • Price
  • BDSX $0.41
  • BDL $30.90
  • Analyst Decision
  • BDSX Strong Buy
  • BDL
  • Analyst Count
  • BDSX 5
  • BDL 0
  • Target Price
  • BDSX $1.75
  • BDL N/A
  • AVG Volume (30 Days)
  • BDSX 1.4M
  • BDL 716.0
  • Earning Date
  • BDSX 08-07-2025
  • BDL 08-12-2025
  • Dividend Yield
  • BDSX N/A
  • BDL 1.70%
  • EPS Growth
  • BDSX N/A
  • BDL 41.91
  • EPS
  • BDSX N/A
  • BDL 2.32
  • Revenue
  • BDSX $76,556,000.00
  • BDL $201,851,000.00
  • Revenue This Year
  • BDSX $17.29
  • BDL N/A
  • Revenue Next Year
  • BDSX $29.33
  • BDL N/A
  • P/E Ratio
  • BDSX N/A
  • BDL $13.25
  • Revenue Growth
  • BDSX 25.70
  • BDL 8.84
  • 52 Week Low
  • BDSX $0.17
  • BDL $22.61
  • 52 Week High
  • BDSX $2.04
  • BDL $35.98
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 53.27
  • BDL 47.15
  • Support Level
  • BDSX $0.37
  • BDL $30.00
  • Resistance Level
  • BDSX $0.43
  • BDL $31.34
  • Average True Range (ATR)
  • BDSX 0.04
  • BDL 0.47
  • MACD
  • BDSX -0.00
  • BDL -0.15
  • Stochastic Oscillator
  • BDSX 48.25
  • BDL 26.39

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: